EBS News and Press, Emergent Biosolutions Inc.

New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...

GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...

The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...

2024-07-21 07:03:59 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead

2024-07-19 15:00:00 ET More on the markets S&P 500: AI Funding Is Needed Amid Inflation And Federal Debt Fed Needs To Cut Rates Immediately Game-Changing CPI Report May Drive Big Rotation Towards Value And SmallCap Not the time to buy the dip - Goldman's ...

2024-07-17 04:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-15 08:55:00 ET Summary The S&P 500 notched its 37th record high on Wednesday of last week. The best-performing groups last week were the small caps. The Goldilocks scenario would be a continuation of the broadening out to include small and mid-caps, while still kee...

2024-07-15 06:28:12 ET Summary Emergent BioSolutions is a commercial stage company focused on developing vaccines and therapeutics to protect against public health threats worldwide. The company experienced a steep decline in stock value due to manufacturing mishaps and scandal du...

GAITHERSBURG, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today highlights several recent advancements in improving its financial health, marked by robust cash generation and meaningful debt repayment. As set forth in its operational plan to transform the company...

2024-07-09 06:00:29 ET Emergent BioSolutions ( NYSE: EBS ) and Johnson & Johnson ( NYSE: JNJ ) have reached a settlement agreement to resolve all claims related to a now-terminated manufacturing services deal for the latter's COVID-19 vaccine.... Read the full ...